Furukawa Y - Search Results

1

Current concepts in the diagnosis and management of Parkinson's disease.

Guttman M, Kish SJ, Furukawa Y. Guttman M, et al. Among authors: furukawa y. CMAJ. 2003 Feb 4;168(3):293-301. CMAJ. 2003. PMID: 12566335 Free PMC article. Review.

2

Brain proteasomal function in sporadic Parkinson's disease and related disorders.

Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Furukawa Y, et al. Ann Neurol. 2002 Jun;51(6):779-82. doi: 10.1002/ana.10207. Ann Neurol. 2002. PMID: 12112087

3

Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.

Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG. Furukawa Y, et al. Ann Neurol. 2002 May;51(5):637-41. doi: 10.1002/ana.10175. Ann Neurol. 2002. PMID: 12112113

4

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Among authors: furukawa y. Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486. Mov Disord. 2003. PMID: 14502663

5

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Tong J, et al. Among authors: furukawa y. Ann Neurol. 2004 Jan;55(1):125-9. doi: 10.1002/ana.10814. Ann Neurol. 2004. PMID: 14705122

6

Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.

Furukawa Y, Filiano JJ, Kish SJ. Furukawa Y, et al. Mov Disord. 2004 Oct;19(10):1256-8. doi: 10.1002/mds.20194. Mov Disord. 2004. PMID: 15389992

7

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Kish SJ, et al. Among authors: furukawa y. Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22. Brain. 2008. PMID: 17956909

8

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Boileau I, et al. Among authors: furukawa y. Brain. 2009 May;132(Pt 5):1366-75. doi: 10.1093/brain/awn337. Epub 2009 Jan 19. Brain. 2009. PMID: 19153147

9

Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia.

Furukawa Y, Kish SJ. Furukawa Y, et al. Brain. 2015 May;138(Pt 5):e351. doi: 10.1093/brain/awu325. Epub 2014 Nov 21. Brain. 2015. PMID: 25416181 Free PMC article. No abstract available.

10

[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.

Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. Payer DE, et al. Among authors: furukawa y. Mov Disord. 2015 Feb;30(2):160-6. doi: 10.1002/mds.26135. Epub 2015 Jan 14. Mov Disord. 2015. PMID: 25641350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,390 results

Search Page

Filters